跳至主要内容
临床试验/NCT00859196
NCT00859196已完成4 期

A Randomized, Double-blind, Single Centre, Placebo-controlled Pilot Study to Assess on a Molecular Level the Influence of a 5 % Dexpanthenol Ointment in Subjects With Previously Injured Skin by Investigation of Skin Biopsies

Bayer0 个研究点目标入组 15 人开始时间: 2009年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
Bayer
入组人数
15
主要终点
Investigation of gene expression in dermal fibroblasts and keratinocytes on a molecular level.

研究概览

简要总结

In previous in vitro studies it could be shown, that Dexpanthenol has an influence on the gene expression of fibroblasts. The genes which are influenced by Dexpanthenol play mainly a role during cell proliferating processes.The aim of this study is to investigate the molecular effect of Dexpanthenol on human living skin, during wound healing.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Skin type I to IV
  • Willingness to avoid intensive sunlight exposure two weeks before the start of the study and at least 2 months after removal of the stitches

排除标准

  • Active skin disease, moles, tattoos, strong pigmentation at the test area or scars in the test area that would influence the visual scoring
  • History of keloids and hypertrophic scars
  • Frequent visits of tanning booths
  • Intake of drugs interfering with the immune system (e.g. antiphlogistics, corticosteroids, immunosuppressants, and antihistamines) within 30 days before day 1 as well as during the study.

研究组 & 干预措施

Arm 1

Experimental

干预措施: Dexpanthenol (BAY81-2996) (Drug)

Arm 2

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

Investigation of gene expression in dermal fibroblasts and keratinocytes on a molecular level.

时间窗: Analysis of skin biopsies taken 24h, 72h and 144h after wounding

次要结局

未报告次要终点

研究者

发起方
Bayer
申办方类型
Industry
责任方
Sponsor

相似试验